Digital PCR for MRD detection of myeloma

Publication Type:
Conference Proceeding
Clinical Lymphoma, Myeloma & Leukemia, 2015, 15 (Supplement 3), pp. E95 - E95 (1)
Issue Date:
Filename Description Size
Thumbnail15th-International-Myeloma-Wokshop.pdf Published version125.2 kB
Adobe PDF
Full metadata record
A pilot study was performed to investigate the use of digital PCR (dPCR) to detect minimal residual disease (MRD) in patients with multiple myeloma. dPCR allows greater quantitative specificity in PCR reactions by performing multiple, minute PCR reactions on individual DNA templates.
Please use this identifier to cite or link to this item: